Essa Shares Plummet as Merger Terms Are Slashed
27.09.2025 - 08:09:03 | boerse-global.de
Investors in Essa have reacted harshly to a severe downgrade in the proposed terms for its business combination with XenoTherapeutics. The announcement has triggered a significant sell-off, eroding shareholder confidence and driving the stock price sharply lower.
The negative sentiment was immediately reflected in the market. Essa’s stock tumbled nearly 9.69% over the past 24-hour period, bringing its weekly loss to approximately 7.26%. The most dramatic move occurred in pre-market trading following the news, where shares plummeted by 17%, indicating a decisive punitive response from the investment community.
Drastic Reduction in Shareholder Payouts
The core issue lies in the radically altered conditions of the merger. Shareholders are now set to receive a cash dividend of just $0.12 per share,... Read more...
So schätzen die Börsenprofis Essa Aktien ein!
Für. Immer. Kostenlos.
